KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Raw Materials (2016 - 2025)

Historic Raw Materials for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Abbott Laboratories' Raw Materials fell 828.13% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 828.13%. This contributed to the annual value of $1.7 billion for FY2024, which is 897.08% down from last year.
  • Latest data reveals that Abbott Laboratories reported Raw Materials of $1.6 billion as of Q3 2025, which was down 828.13% from $1.7 billion recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Raw Materials peaked at $2.0 billion during Q2 2023, and registered a low of $1.4 billion during Q4 2021.
  • For the 5-year period, Abbott Laboratories' Raw Materials averaged around $1.7 billion, with its median value being $1.7 billion (2025).
  • Per our database at Business Quant, Abbott Laboratories' Raw Materials surged by 2916.67% in 2021 and then plummeted by 1072.57% in 2025.
  • Quarter analysis of 5 years shows Abbott Laboratories' Raw Materials stood at $1.4 billion in 2021, then increased by 22.14% to $1.7 billion in 2022, then increased by 7.64% to $1.8 billion in 2023, then dropped by 8.97% to $1.7 billion in 2024, then fell by 2.24% to $1.6 billion in 2025.
  • Its Raw Materials was $1.6 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $1.7 billion in Q1 2025.